Laboratoire de Microsystèmes LMIS4, Ecole Polytechnique Fédérale de Lausanne, Station 17, CH-1015 Lausanne, Switzerland.
Biotechnol Bioeng. 2011 Sep;108(9):2241-5. doi: 10.1002/bit.23128. Epub 2011 Mar 21.
This communication presents a novel experimental model for Alzheimer studies, where connected primary neurons were set into subtend, co-pathological states. Cortical neurons were cultured in two separated cell compartments in a microfluidic device. A neurite network was generated in a main channel through the neurite outgrowth from both cell compartments. A gradient of okadaic acid (OA) is generated over this neurite network by perfusion. OA is a phosphatase inhibitor that induces hyperphosphorylation of Tau proteins, a major hallmark in Alzheimer disease. The local OA treatment resulted in a connected "diseased" and "healthy" cell population. Anti-phosphorylated tau (Ser262) staining confirmed different states of phosphorylated Tau proteins, and synapthophysin staining the connection of "healthy" and "diseased" cells. Here, we present a novel in vitro model that opens the possibility to study cellular and molecular propagation mechanisms in neurodegeneration, in Tauopathies (as e.g., in Alzheimer), as well as simultaneous drug effects on connected healthy and diseased cell populations.
本研究提出了一种阿尔茨海默病研究的新型实验模型,该模型中连接的原代神经元处于共病理状态。皮质神经元在微流控装置的两个分离的细胞隔室中培养。通过来自两个细胞隔室的突起生长,在主通道中产生神经突网络。通过灌注在该神经突网络上产生岗田酸(OA)的浓度梯度。OA 是一种磷酸酶抑制剂,可诱导 Tau 蛋白过度磷酸化,这是阿尔茨海默病的主要标志之一。局部 OA 处理导致连接的“患病”和“健康”细胞群体。抗磷酸化 Tau(Ser262)染色证实了磷酸化 Tau 蛋白的不同状态,突触小体蛋白染色则证实了“健康”和“患病”细胞的连接。在这里,我们提出了一种新型的体外模型,为研究神经退行性疾病、Tau 病(如阿尔茨海默病)中的细胞和分子传播机制,以及同时对连接的健康和患病细胞群体的药物作用提供了可能。